COVID-19相关急性呼吸窘迫综合征的病理生理学:多中心前瞻性观察研究
该前瞻性观察研究在意大利7家医院纳入301例机械通气的COVID-19 ARDS患者,发现中位静态顺应性为41 mL/cm H2O,比非COVID-19 ARDS队列高28%;D-二聚体高于中位数且静态顺应性低于中位数的患者28天死亡率显著增高。
要点
- COVID-19 ARDS患者中位静态顺应性41 mL/cm H2O,高于经典ARDS的32 mL/cm H2O。
- D-二聚体高于中位数者更易出现双侧低灌注区,提示血栓栓塞性疾病。
- 高D-二聚体合并低静态顺应性患者28天死亡率高达56%。
核心结论
- COVID-19相关ARDS的损伤形式在许多方面与非COVID-19 ARDS相似。
- COVID-19 ARDS患者若呼吸系统顺应性降低且D-二聚体浓度升高,死亡率高。
研究设计与样本
- 前瞻性观察研究,在意大利7家医院进行。
- 纳入2020年3月9日至3月22日连续机械通气、实验室确诊COVID-19且符合柏林ARDS标准的ICU患者,共301例。
- 所有患者镇静、麻痹并以容量控制模式通气,入住ICU 24小时内测量静态呼吸系统顺应性、PaO2/FiO2、通气比和D-二聚体。
- 临床指征时行肺部CT和CT血管造影,并与既往非COVID-19 ARDS研究数据集比较,评估第28天生存率。
主要发现
- 297例COVID-19 ARDS患者中17例(6%)静态顺应性超过经典ARDS队列的第95百分位数。
- 两队列总肺重量无差异。
- 23例(8%)COVID-19 ARDS患者行CT肺动脉造影,其中D-二聚体高于中位数的16例中15例(94%)显示双侧低灌注区,符合血栓栓塞性疾病。
临床怎么用
- 对COVID-19 ARDS患者应监测静态呼吸系统顺应性和D-二聚体,以识别高死亡风险亚组。
- D-二聚体升高提示可能存在血栓栓塞性疾病,临床可考虑行CT肺动脉造影评估。
局限性
- CT肺动脉造影仅在23例(8%)患者中进行,样本量小。
- 非COVID-19 ARDS数据集来自既往研究,非同期对照。
- 研究为观察性设计,不能推断因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with COVID-19 can develop acute respiratory distress syndrome (ARDS), which is associated with high mortality. The aim of this study was to examine the functional and morphological features of COVID-19-associated ARDS and to compare these with the characteristics of ARDS unrelated to COVID-19. METHODS: This prospective observational study was done at seven hospitals in Italy. We enrolled consecutive, mechanically ventilated patients with laboratory-confirmed COVID-19 and who met Berlin criteria for ARDS, who were admitted to the intensive care unit (ICU) between March 9 and March 22, 2020. All patients were sedated, paralysed, and ventilated in volume-control mode with standard ICU ventilators. Static respiratory system compliance, the ratio of partial pressure of arterial oxygen to fractional concentration of oxygen in inspired air, ventilatory ratio (a surrogate of dead space), and D-dimer concentrations were measured within 24 h of ICU admission. Lung CT scans and CT angiograms were done when clinically indicated. A dataset for ARDS unrelated to COVID-19 was created from previous ARDS studies. Survival to day 28 was assessed. FINDINGS: Between March 9 and March 22, 2020, 301 patients with COVID-19 met the Berlin criteria for ARDS at participating hospitals. Median static compliance was 41 mL/cm H2O (33-52), which was 28% higher than in the cohort of patients with ARDS unrelated to COVID-19 (32 mL/cm H2O [25-43]; p<0·0001). 17 (6%) of 297 patients with COVID-19-associated ARDS had compliances greater than the 95th percentile of the classical ARDS cohort. Total lung weight did not differ between the two cohorts. CT pulmonary angiograms (obtained in 23 [8%] patients with COVID-19-related ARDS) showed that 15 (94%) of 16 patients with D-dimer concentrations greater than the median had bilateral areas of hypoperfusion, consistent with thromboembolic disease. Patients with D-dimer concentrations equal to or less than the median had ventilatory ratios lower than those of patients with D-dimer concentrations greater than the median (1·66 [1·32-1·95] vs 1·90 [1·50-2·33]; p=0·0001). Patients with static compliance equal to or less than the median and D-dimer concentrations greater than the median had markedly increased 28-day mortality compared with other patient subgroups (40 [56%] of 71 with high D-dimers and low compliance vs 18 [27%] of 67 with low D-dimers and high compliance, 13 [22%] of 60 with low D-dimers and low compliance, and 22 [35%] of 63 with high D-dimers and high compliance, all p=0·0001). INTERPRETATION: Patients with COVID-19-associated ARDS have a form of injury that, in many aspects, is similar to that of those with ARDS unrelated to COVID-19. Notably, patients with COVID-19-related ARDS who have a reduction in respiratory system compliance together with increased D-dimer concentrations have high mortality rates. FUNDING: None.
引用
- Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020. PMID: 32861276. doi:10.1016/S2213-2600(20)30370-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。